查看购物车
  • Traditional Chinese
  • Japanese
  • Korean
青光眼手术设备市场(2025年):全球市场分析(2024年～2030年)
市场调查报告书
商品编码
1791925

青光眼手术设备市场(2025年):全球市场分析(2024年～2030年)

2025 Glaucoma Surgical Device Market Report: Global Analysis for 2024 to 2030
出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

最新资讯

"青光眼手术器械市场报告 (2025)" 介绍了每个产品类别过去六年的销售历史记录，并分析了影响这些趋势的临床和商业事件，为未来预测提供了关键背景。

新报告重点介绍了一系列针对晚期青光眼的创新结膜下器械，包括 Avis 的超薄滤过板、Myra Vision 的术后可调分流器以及 Ciliatech 的葡萄膜巩膜植入物。此外，报告还重点介绍了 Iantrek 和 iStar Medical 的新型胆道上器械，为外科医生提供了引流部位选择。

下一代青光眼雷射器，例如爱尔康的 Voyager DSLT、ViaLase 的 ViaLuxe 和博士伦的 Elios，预计将推动强劲的收入成长。本报告提供了这些系统的详细资讯以及雷射产业的最新预测。

我们也提供了扩展的区域报销和监管分析，概述了审批途径、政策变化和报销挑战。

"青光眼手术器械市场报告（2025）" 提供了全球青光眼手术器械市场的数据驱动分析，全面涵盖了现有技术、创新管道、竞争定位和区域成长机会。

我们研究了全球青光眼的盛行率和治疗趋势。我们也详细介绍了所有已商业化的器械，包括微型支架、结膜下分流器、鼻道手术器械和导管分流器，并评估了有望改善治疗效果并推动未来应用的在研产品线。

市场细分预测了截至 2030 年的市场需求（以数量和金额计算），并按器械类别、手术类型和地区进行了详细细分。竞争分析包括市场占有率预测、产品推出计划以及 29 家领先和新兴公司的详细概况，重点介绍他们的产品、策略定位以及在这一快速发展领域的前景。

目录

2025 年青光眼手术器械市场概况提供了最全面、最具策略意义的全球市场概览。它涵盖了五个主要器械类别的现有技术和新兴技术：微型支架、结膜下分流器、鼻道手术器械、导管分流器和青光眼雷射。它还提供了详细的五年市场估计和收入预测，以及竞争对手的市场占有率分析。

本报告也包含以下内容：

  • 按国家/地区和设备类型细分的全球市场预测
  • 深入探讨手术趋势、手术方式及医师采用模式
  • 分析美国、欧洲、亚洲和其他主要地区的报销趋势
  • 详细介绍了约 30 家领先和新兴设备製造商的公司简介
  • 新增了关于持续给药设备、雷射技术创新以及手术在青光眼治疗中的作用变化的章节
  • 按房水引流部位对手术器械进行细分，反映了外科医师对治疗方案的实际分类方式

本报告以研究数据和行业领先的市场模型为支撑，旨在成为行业领导者、投资者和策略家了解青光眼治疗设备市场现状和未来方向的重要资源。

简介目录

What's New:

The "2025 Glaucoma Surgical Device Market Report" includes a new six-year sales history for each product category, along with analysis of the clinical and commercial events that shaped those trends to provide crucial context for future projections.

The new report spotlights a wave of innovative subconjunctival devices targeting advanced glaucoma, including Avisi's ultrathin filtration plate, Myra Vision's post-op adjustable shunt, and Ciliatech's uveoscleral implant. It also highlights new supraciliary devices from Iantrek and iStar Medical that offer surgeons additional drainage site options.

Next-generation glaucoma lasers-such as Alcon's Voyager DSLT, ViaLase's ViaLuxe, and Bausch + Lomb's Elios-are expected to drive strong revenue growth. The report details these systems and provides updated forecasts for the laser segment.

Expanded reimbursement and regulatory analysis is now provided by region, outlining approval pathways, policy shifts, and reimbursement challenges.

The "2025 Glaucoma Surgical Device Market Report" provides a data-driven analysis of the global market for glaucoma surgical devices, offering comprehensive coverage of current technologies, innovation pipelines, competitive positioning, and growth opportunities by region.

The report examines global glaucoma prevalence and treatment trends. It details the full spectrum of commercialized devices-including microstents, subconjunctival shunts, canal surgery devices, and tube shunts-and evaluates the pipeline of investigational products that are poised to improve outcomes and drive future adoption.

Market demand is forecast in both units and dollars through 2030, with detailed segmentation by device category, procedure type, and region. Competitive analysis includes market share estimates, plans for product adoption, and detailed profiles of 29 leading and emerging companies, highlighting their products, strategic positioning, and outlook in this rapidly evolving segment.

Contents:

The "2025 Glaucoma Surgical Device Market Report" offers the most comprehensive and strategic overview of the global market to date. It covers current and emerging technologies across five key device categories: microstents, subconjunctival shunts, canal surgery devices, tube shunts, and glaucoma lasers-with detailed five-year forecasts, unit and revenue estimates, and competitor market share analysis.

The report also features:

  • A global market forecast segmented by country/region and device type
  • Deep dives into surgical trends, procedure settings, and physician adoption patterns
  • Analysis of the reimbursement landscape across the US, Europe, Asia, and other major regions
  • In-depth company profiles for nearly 30 leading and emerging device manufacturers
  • New sections on sustained drug-delivery devices, laser innovation, and the changing role of surgery in glaucoma care
  • Updated classification of surgical devices by aqueous drainage site, reflecting how surgeons categorize treatment options in practice

Backed by survey data and industry-leading market modeling, this report is designed to be an essential resource for industry leaders, investors, and strategists seeking to understand where the glaucoma device market stands-and where it's headed next.